![Seok-Mo Kang](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortune : 25 045 $ au 31/05/2026
Seok-Mo Kang currently works at Keyfron Bio Co., Ltd., as Director and Keyprime Research Co., Ltd., as Director.
Dr. Kang also formerly worked at Biotoxtech Co., Ltd., as Executive Board Member & Head-Research Planning.
Dr. Kang received his undergraduate degree and graduate degree from Seoul National University and doctorate degree from Korea Advanced Institute of Science & Technology.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
BIOTOXTECH CO., LTD. 0,09 % | 27/02/2026 | 14 351 ( 0,09 % ) | 25 045 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
Keyfron Bio Co., Ltd. | Directeur/Membre du Conseil | - |
Keyprime Research Co., Ltd.
 Keyprime Research Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Develops non-clinical trial platform for researchers to conduct efficient clinical trials | Directeur/Membre du Conseil | - |
| Sociétés | Poste | Fin |
|---|---|---|
| BIOTOXTECH CO., LTD. | Directeur Technique/Scientifique/R&D | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 5 |
|---|---|
Seoul National University
 Seoul National University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Korea Advanced Institute of Science & Technology
 Korea Advanced Institute of Science & Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Biotoxtech Co., Ltd.
 Biotoxtech Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in the provision of non-clinical drug trials | Commercial Services |
Keyfron Bio Co., Ltd. | |
Keyprime Research Co., Ltd.
Keyprime Research Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Develops non-clinical trial platform for researchers to conduct efficient clinical trials | Commercial Services |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
